Value of 18F-FDG metabolic imaging in diagnosis and treatment of head and neck tumors and its mechanism study

National Medical Journal of China

Volumn 87, Issue 2, 2007, Pages 109-113

  Zhou, Shui Hong ^a   Wu, Qiu Liang ^a   Wang, Shen Qing ^a   Fan, Jun ^a   Li, Ling Fa ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Fludeoxyglucose F18; Head and neck neoplasm; Monosaccharide transport proteins; Tomography, emission computed

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; MESSENGER RNA; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; GLUCOSE TRANSPORT; HEAD AND NECK TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE QUALITY; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; MICROSCOPIC ANATOMY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSPORT KINETICS; BIOSYNTHESIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 3; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 33947107924     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Warburg O, Wind F, Negalein E. The metabolism of tumors in the body. J Physiol, 1927,8:519-530.
2. Hatanaka M. Transport of sugars in tumor cell membranes. Biochem Biophys Acta, 1974, 355:77-104.
3. Youne M, Brown RW, Stephenson M, et al. Overexpression of Glut-1 and Glut-3 in stage I nonsmall cell lung carcinoma is associated with poor surival. Cancer, 1997, 80:1046-1051.
4. Yamamoto T, Seino Y, Fukumoto H, et al. Over-expression of faciliative glucose transporter genes in human cancer. Biochem Biophys Res Commun, 1990, 170:223-230.
5. 18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma. Oncology, 2003,64:336-340.
6. 18F-FDG-PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med, 2002, 43:173-180.
7. 18 F] fluorodeoxyglucose in the pretreatment evaluation of patients with oesophageal cancer. Nucl Med Commun, 2003,24: 963-970.
8. Lowe VJ, Boyd JH, Dunphy FR, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol, 2000,18:651-658.
9. Chinese source.
10. Wahl RL, Quint LE, Greenough RL, et al. Staging non-small cell lung cancer with FDG-PET, CT and fusion images: preliminary prospective valuation. Radiology, 1994, 191:371.
11. Chinese source.
12. Reisser C, Eichhorn K, Heroid-Mende, et al. Expression of facilitative glucose transporter proteins during development of squamous cell carcinomas of the head and neck. Int J Cancer, 1999,80:194-198.
13. Chinese source.
14. Chinese source.